0
Allena Pharmaceuticals, Inc. Banner Image

Allena Pharmaceuticals, Inc. has reached its limit for free report views

Work for Allena Pharmaceuticals, Inc.? Upgrade Your Profile and unlock all your annual reports.

Allena Pharmaceuticals, Inc.

  • Ticker ALNA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Allena Pharmaceuticals, Inc. Logo Image
  • 11-50 Employees
  • Based in Newton, Massachusetts
Allena Pharmaceuticals, Inc. is a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena’s lead product candidate, reloxaliase, is a first in class, oral enzyme therapeutic for the treatment of hyperoxaluria, a metabolic disorder characterizedMore by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders.
Allena Pharmaceuticals, Inc.

Most Recent Annual Report

Allena Pharmaceuticals, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Allena Pharmaceuticals, Inc. has reached its limit for free report views.

Older/Archived Annual Reports